Article in The Aesthetic Surgery Journal Encourages FDA to Implement New Strategies to Protect Patients Seeking Cosmetic Stem-Cell Treatments
New York, NY (March 12, 2019) – A recent article published in the Aesthetic Surgery Journal, the clinical, peer-reviewed journal of the American Society for Aesthetic Plastic Surgery (The Aesthetic Society) is calling for the FDA to expedite its oversight of companies and clinics offering stem-cell products and therapies.